Yoshimura T, Kurita C, Yamazaki F, Nakano S, Nagai H
Pharmaceutical Division, Ogaki Municipal Hospital, Gifu, Japan.
Biol Pharm Bull. 1994 Jul;17(7):921-6. doi: 10.1248/bpb.17.921.
The lymphocyte stimulation test (LST) is useful for diagnosing drug-induced allergy and identifying the causative drug. In this study, we examined the usefulness of 3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) as a marker for LST in diagnosing drug allergy. In a basic study using normal peripheral blood mononuclear cells, the normal range of stimulation index (SI) was 0.92-1.38, and the mean SI for all drugs tested was 1.134 +/- 0.111 (mean +/- S.D.). The cut-off value of SI for diagnosis of drug allergy was thus set at over mean + 2S.D. for possibly positive, and at over mean + 3S.D. as a definitely positive reaction. Forty-six cases of suspected drug-induced allergic hepatitis involving 85 drugs were diagnosed by this assay, and the possibly positive and definitely positive rates were 54.3% (SI > or = 1.4) and 41.3% (SI > or = 1.5), respectively. A clinical study was made of 113 patients with diagnosed drug-induced allergic hepatitis. Forty-nine (43%) of the patients were male and 64 (57%) were female. In 85% of cases the allergic reaction occurred within one month of taking medication, but there were a number of cases in whom onset occurred after long-term incubation. The main clinical symptoms were jaundice, itching, eruption, fever, and general malaise. In about 75% of cases glutamic oxaloacetic transaminase (GOT) or glutamic pyruvic transaminase (GPT) returned to normal range within one month after medication was halted.(ABSTRACT TRUNCATED AT 250 WORDS)
淋巴细胞刺激试验(LST)有助于诊断药物性过敏并确定致病药物。在本研究中,我们检测了3-(4,5-二甲基噻唑-2-基)-2,5-二苯基溴化四氮唑(MTT)作为LST标志物在诊断药物过敏中的实用性。在一项使用正常外周血单核细胞的基础研究中,刺激指数(SI)的正常范围为0.92 - 1.38,所有受试药物的平均SI为1.134±0.111(平均值±标准差)。因此,诊断药物过敏的SI临界值设定为高于平均值 + 2个标准差为可能阳性,高于平均值 + 3个标准差为肯定阳性反应。通过该检测方法诊断了46例疑似药物性过敏性肝炎病例,涉及85种药物,可能阳性率和肯定阳性率分别为54.3%(SI≥1.4)和41.3%(SI≥1.5)。对113例确诊为药物性过敏性肝炎的患者进行了临床研究。其中49例(43%)为男性,64例(57%)为女性。85%的病例过敏反应发生在服药后1个月内,但也有一些病例在长期潜伏期后发病。主要临床症状为黄疸、瘙痒、皮疹、发热和全身不适。约75%的病例在停药后1个月内谷草转氨酶(GOT)或谷丙转氨酶(GPT)恢复到正常范围。(摘要截取自250字)